CHCT Stock Community Healthcare Trust Incorporated
US · NYSELast in our picks 2026-10-04 — not in the current list; analysis below is from that screen
Niche healthcare properties offer higher yield and potential valuation recovery.
Future value: $17.50 (+28.49%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Potentially attractive, but liquidity and momentum are weaker.
- ▾Below 50-day MA (-11.27%)
- ▸Volume 1.54× average — accumulation
- ▾Near 52-week low (6.6% of range)
- ▸~28% upside to price target
Is CHCT a buy right now?
Trend: CHCT is trading below the 50-day average (-9.03%), RSI 38 — neutral momentum, with a 3-month return of -32.18%.
Valuation & quality: Community Healthcare Trust Incorporated trades on a trailing P/E of 19.8, forward P/E 32.3, price-to-book 0.84; fundamentals show net margin 16.8%, return on equity 4.9%, revenue growth 7.4% year on year.
Analyst consensus: 4 analysts have a mean 12-month price target of $16.50 (+27.9% vs the last close; range $14.00 – $18.00), consensus rating “none”.
Income: trailing dividend yield 13.66%.
Our screen: BUY (score 2) — Niche healthcare properties offer higher yield and potential valuation recovery.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -7.00% | +8.40% | +0.00% | +6.20% | +0.20% | -19.70% | -3.60% | -9.00% |
Fundamentals
Analyst price target
Technical signals
About Community Healthcare Trust Incorporated
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States.
Sector: Real Estate · Industry: REIT - Healthcare Facilities · United States · 35 employees · Website
Related Real Estate picks
Browse: all US stocks · Real Estate picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.